Oruka Therapeutics, Inc. ORKA Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s software and technology licenses, net?
- Oruka Therapeutics, Inc. (ORKA) reported software and technology licenses, net of $103K in Q1 2026.
- How has Oruka Therapeutics, Inc.'s software and technology licenses, net changed year-over-year?
- Oruka Therapeutics, Inc.'s software and technology licenses, net decreased by 0.0% year-over-year, from $103K to $103K.
- What is the long-term trend for Oruka Therapeutics, Inc.'s software and technology licenses, net?
- Over 5 years (2020 to 2025), Oruka Therapeutics, Inc.'s software and technology licenses, net has grown at a 53.7% compound annual growth rate (CAGR), from $12K to $103K.